Drug General Information
Drug ID
D0R9CF
Former ID
DNC008845
Drug Name
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531235]
Structure
Download
2D MOL

3D MOL

Formula
C21H18O5
Canonical SMILES
C1=CC=C(C=C1)OCCCCOC2=C3C=CC(=O)OC3=CC4=C2C=CO4
InChI
1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2
InChIKey
KINMYBBFQRSVLL-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily A member 3 Target Info Inhibitor [531235]
Calcium-activated potassium channel Target Info Inhibitor [530011]
Potassium voltage-gated channel subfamily A member 5 Target Info Inhibitor [531235]
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channelsR-HSA-1296072:Voltage gated Potassium channels
WikiPathways Potassium Channels
BDNF signaling pathwayWP2669:Potassium Channels
References
Ref 531235Bioorg Med Chem Lett. 2010 Dec 1;20(23):6989-92. Epub 2010 Oct 23.Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2.
Ref 530011Bioorg Med Chem Lett. 2009 Apr 15;19(8):2299-304. Epub 2009 Feb 25.Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.
Ref 531235Bioorg Med Chem Lett. 2010 Dec 1;20(23):6989-92. Epub 2010 Oct 23.Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.